Security key
21217B100
Contineum Therapeutics, Inc. - Class A Stock (CTNM)
CUSIP: 21217B100
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Class A Stock
- Total 13F shares
- 13,713,806
- Total 13F value
- $258,404,333
- Share change
- +682,541
- SEC-reported price per share
- $19.14
- Number of holders
- 52
- Value change
- +$11,041,962
- Number of buys
- 21
- Number of sells
- 21
- Shares outstanding
- 32,531,635
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
52
Top holders
10
CTNM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Contineum Therapeutics, Inc. SEC filings
Contineum Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21217B100
Recent filing periods:
Ownership snapshot
Top reported holders of CTNM - Contineum Therapeutics, Inc. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SUVRETTA CAPITAL MANAGEME...
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 6.3%
Showing 1-6 of 15 holder rows.
Quick read
SUVRETTA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 6.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SUVRETTA CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SUVRETTA CAPITAL MANAGEMENT, LLC
6.3%
JOHNSON & JOHNSON
6.1%
PERCEPTIVE ADVISORS LLC
4.8%
Versant Venture Management, LLC
2.8%
SECTORAL ASSET MANAGEMENT INC
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
6.3%
|
$36,159,212
2,053,334 shares
|
— | 30 Jun 2024 |
| JOHNSON & JOHNSON |
13F
3/4/5
Company · 10%+ Owner
|
6.1%
|
$34,853,237
1,979,173 shares
|
— | 30 Jun 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
4.8%
|
$27,589,023
1,566,668 shares
|
— | 30 Jun 2024 |
| Versant Venture Management, LLC |
13F
Company
|
2.8%
|
$16,168,850
918,163 shares
|
— | 30 Jun 2024 |
| SECTORAL ASSET MANAGEMENT INC |
13F
Company
|
2.5%
|
$14,103,620
800,887 shares
|
— | 30 Jun 2024 |
| HHLR ADVISORS, LTD. |
13F
Company
|
2.1%
|
$11,787,025
669,337 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
52
Shares
13,713,806
Rows available
52
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
49
Q3 2024 holders
52
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend